BEAM vs CUBE
Beam Therapeutics Inc (BEAM) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BEAM currently screens at market cap $2.01B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BEAM and CUBE stock pages for the full models.
Not investment advice.